Stocks
Hologic Financial Statements (HOLX) |
||||||||||
| Hologicsmart-lab.ru | % | 2022 | 2022 | 2023 | 2023 | 2024 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 24.09.2022 | 15.11.2022 | 30.09.2023 | 21.11.2023 | 30.09.2024 | 04.11.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 4 863 | 4 863 | 4 030 | 4 030 | 4 029 | ||||
| Operating Income, bln rub | 1 640 | 1 640 | 668.4 | 668.4 | 1 001 | |||||
| EBITDA, bln rub | ? | 1 773 | 2 113 | 1 204 | 1 111 | 1 327 | ||||
| Net profit, bln rub | ? | 1 302 | 1 302 | 456.0 | 456.0 | 737.5 | ||||
| OCF, bln rub | ? | 2 126 | 2 126 | 1 051 | 1 051 | 1 104 | ||||
| CAPEX, bln rub | ? | 70.6 | 127.2 | 150.2 | 150.2 | 115.8 | ||||
| FCF, bln rub | ? | 2 055 | 1 999 | 901.0 | 901.0 | 988.2 | ||||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0 | |||||
| OPEX, bln rub | 1 357 | 1 367 | 1 310 | 1 310 | 1 256 | |||||
| Cost of production, bln rub | 1 865 | 1 865 | 1 959 | 1 959 | 1 772 | |||||
| R&D, bln rub | 283.4 | 283.4 | 294.3 | 294.3 | 270.1 | |||||
| Interest expenses, bln rub | 95.1 | 95.1 | 111.1 | 111.1 | 128.1 | |||||
| Assets, bln rub | 9 071 | 9 071 | 9 139 | 9 139 | 9 156 | 9 156 | ||||
| Net Assets, bln rub | ? | 4 876 | 4 876 | 5 017 | 5 017 | 5 130 | 5 130 | |||
| Debt, bln rub | 2 823 | 2 823 | 2 818 | 2 818 | 2 535 | 2 535 | ||||
| Cash, bln rub | 2 340 | 2 340 | 2 723 | 2 723 | 2 334 | 2 334 | ||||
| Net debt, bln rub | 483.9 | 483.9 | 95.7 | 95.7 | 201.0 | 201.0 | ||||
| Ordinary share price, rub | 63.0 | 63.0 | 69.4 | 69.4 | 81.5 | 66.6 | ||||
| Number of ordinary shares, mln | 251.5 | 251.5 | 246.8 | 246.8 | 233.8 | |||||
| Market cap, bln rub | 15 841 | 15 841 | 17 126 | 17 126 | 0 | 15 560 | ||||
| EV, bln rub | ? | 16 325 | 16 325 | 17 222 | 17 222 | 201 | 15 761 | |||
| Book value, bln rub | 4 876 | 359 | 5 017 | 847 | 5 130 | 5 130 | ||||
| EPS, rub | ? | 5.18 | 5.18 | 1.85 | 1.85 | 3.15 | ||||
| FCF/share, rub | 8.17 | 7.95 | 3.65 | 3.65 | 4.23 | |||||
| BV/share, rub | 19.4 | 1.43 | 20.3 | 3.43 | 21.9 | |||||
| EBITDA margin, % | ? | 36.5% | 43.5% | 29.9% | 27.6% | 32.9% | ||||
| Net margin, % | ? | 26.8% | 26.8% | 11.3% | 11.3% | 18.3% | ||||
| FCF yield, % | ? | 13.0% | 12.6% | 5.26% | 5.26% | 0.00% | 6.35% | |||
| ROE, % | ? | 26.7% | 26.7% | 9.09% | 9.09% | 0.00% | 14.4% | |||
| ROA, % | ? | 14.4% | 14.4% | 4.99% | 4.99% | 0.00% | 8.05% | |||
| P/E | ? | 12.2 | 12.2 | 37.6 | 37.6 | 21.1 | ||||
| P/FCF | 7.71 | 7.93 | 19.0 | 19.0 | 15.7 | |||||
| P/S | ? | 3.26 | 3.26 | 4.25 | 4.25 | 3.86 | ||||
| P/BV | ? | 3.25 | 44.1 | 3.41 | 20.2 | 0.00 | 3.03 | |||
| EV/EBITDA | ? | 9.21 | 7.72 | 14.3 | 15.5 | 11.9 | ||||
| Debt/EBITDA | 0.27 | 0.23 | 0.08 | 0.09 | 0.15 | |||||
| R&D/CAPEX, % | 401.4% | 222.8% | 195.9% | 195.9% | 233.2% | |||||
| CAPEX/Revenue, % | 1.45% | 2.62% | 3.73% | 3.73% | 2.87% | |||||
| Hologic shareholders | ||||||||||
